ultra-long-acting basal insulin/fast-acting insulin aspart (GZR101) - Gan & Lee Pharma
NovoLog (insulin aspart) - Novo Nordisk
DegludecPlus (insulin degludec/insulin aspart) - Novo Nordisk
http://clinicaltrials.gov/ct2/show/NCT07387003
 
Feb 5, 2026
 
Next